#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA2162825	B	Inhibition of human Hex A using 4-MU-GlcNAc as substrate after 10 mins by Lineweaver Burk plot analysis	Homo sapiens	1		single protein format	Scientific Literature
2.	ALA985859	B	Activation of beta Hex A alpha G269S/c.1278insTACT mutant isolated from Tay-Sachs disease patient assessed as increase in HEX A activity relative to control	Homo sapiens	1		single protein format	Scientific Literature
3.	ALA985860	B	Activation of beta Hex A alpha IVS9 + 1G>A/IVS8-7G>A mutant isolated from Tay-Sachs disease patient assessed as increase in HEX A activity relative to control	Homo sapiens	1		single protein format	Scientific Literature
4.	ALA985861	B	Activation of beta Hex A alpha G269S/c.1278insTACT mutant isolated from Tay-Sachs disease patient assessed as increase in HEX A activity at 300 ug/ml relative to control	Homo sapiens	1		single protein format	Scientific Literature
5.	ALA985862	B	Activation of beta Hex A alpha IVS9 + 1G>A/IVS8-7G>A mutant isolated from Tay-Sachs disease patient assessed as increase in HEX A activity at 300 ug/ml relative to control	Homo sapiens	1		single protein format	Scientific Literature
6.	ALA985863	B	Activation of beta Hex A alphaG269S mutant isolated from Tay-Sachs disease patient assessed as increase in activator-[3H]GM2 complex hydrolysis at 3 ug/ml relative to control	Homo sapiens	1		single protein format	Scientific Literature
7.	ALA986740	B	Activation of beta Hex A alphaG269S mutant isolated from Tay-Sachs disease patient assessed as increase in 4-methylumbelliferyl-7-(6-sulfo-2-acetamido-2-deoxy)-beta-D-glucopyranoside hydrolysis at 3 ug/ml relative to control	Homo sapiens	1		single protein format	Scientific Literature
8.	ALA986750	B	Pharmacological chaperone effect on beta Hex A beta-G353R/IVS12-26G>A mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
9.	ALA986751	B	Pharmacological chaperone effect on beta Hex A beta-G353R/IVS12-26G>A mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
10.	ALA986752	B	Pharmacological chaperone effect on beta Hex A beta-G353R/IVS12-26G>A mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
11.	ALA986753	B	Pharmacological chaperone effect on beta Hex A beta-G353R/IVS12-26G>A mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
12.	ALA983114	B	Pharmacological chaperone effect on beta Hex A beta-R505Q/IVS11 + 5G>A mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
13.	ALA983115	B	Pharmacological chaperone effect on beta Hex A beta-R505Q/IVS11 + 5G>A mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
14.	ALA983116	B	Pharmacological chaperone effect on beta Hex A beta-R505Q/IVS11 + 5G>A mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 3 ug/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
15.	ALA983117	B	Pharmacological chaperone effect on beta Hex A beta-R505Q/IVS11 + 5G>A mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX S activity at 300 mg/ml by immunoselection assay relative to control	Homo sapiens	1		single protein format	Scientific Literature
16.	ALA983126	B	Pharmacological chaperone effect on beta Hex A alpha G269S/c.1278ins TACT mutant in fibroblasts from Tay-Sachs disease patient assessed as increase in HEX A activity relative to control	Homo sapiens	2		single protein format	Scientific Literature
17.	ALA983127	B	Pharmacological chaperone effect on beta Hex A alpha G269S/IV6 + 1G>A mutant in fibroblasts from Tay-Sachs disease patient assessed as increase in HEX A activity relative to control	Homo sapiens	2		single protein format	Scientific Literature
18.	ALA983128	B	Pharmacological chaperone effect on beta Hex A alpha IVS9 + 1G>A/IVS8-7G>A mutant in fibroblasts from Tay-Sachs disease patient assessed as increase in HEX A activity relative to control	Homo sapiens	1		single protein format	Scientific Literature
19.	ALA983129	B	Activation of on beta Hex A beta R505Q/IVS11 + 5G>A mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity relative to control	Homo sapiens	2		single protein format	Scientific Literature
20.	ALA983132	B	Pharmacological chaperone effect on beta Hex A beta G353R/IVS12-26G>A mutant in fibroblasts from Sandhoff disease patient assessed as increase in HEX A activity relative to control	Homo sapiens	2		single protein format	Scientific Literature